Bell's palsy characteristics, clinical manifestations, complications, and prognosis in a primary care setting, a single center study: A retrospective cohort study
- PMID: 39722915
- PMCID: PMC11668478
- DOI: 10.4103/jfmpc.jfmpc_664_24
Bell's palsy characteristics, clinical manifestations, complications, and prognosis in a primary care setting, a single center study: A retrospective cohort study
Abstract
Background: Bell's palsy (BP) is a cranial nerve disorder in which unilateral or bilateral paralysis of the facial nerve occurs. The study aims to study BP's characteristics, including its clinical manifestations, prognosis, and complications among adult patients aged 18 years and above.
Methods: A retrospective study of adult patients diagnosed with BP in a primary care setting] [January 2015 to December 2022].
Results: The study included a total number of 92 patients with an incidence rate of 23 cases per 100,000 people. The mean age was 43.52 years. The most common symptoms reported were dropping of the mouth at 38.9%, loss of forehead muscle movement at 24.4%, loss of nasolabial fold at 22.2%, loss of facial expressions at 20%, and headache at 18.9%. Immunodeficiency affected 2.3% of the patients. The management of patients involved the use of steroids in 76.1% and the use of antiretroviral medications in 48.9%. Physiotherapy was used in 29.5%. The complete recovery rate during the first year was 90.8%. The rate of complete recovery within two years was 96.9%.
Conclusion: The incidence of BP in the region seems to be similar to the incidence rate reported elsewhere in the world. The use of antiviral therapy seems to be high despite the controversy around the use of antivirals in the management of BP. The majority of patients with BP recover within the first year.
Keywords: Bell’s palsy; clinical features; epidemiology; facial nerve paralysis; primary care; prognosis.
Copyright: © 2024 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Clinical practice guideline: Bell's palsy.Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27. doi: 10.1177/0194599813505967. Otolaryngol Head Neck Surg. 2013. PMID: 24189771
-
Incidence rate, risk factors, and management of Bell's palsy in the Qurayyat region of Saudi Arabia.PeerJ. 2022 Oct 6;10:e14076. doi: 10.7717/peerj.14076. eCollection 2022. PeerJ. 2022. PMID: 36221264 Free PMC article.
-
A Retrospective Review of Seasonal Patterns of Idiopathic Facial Nerve Paralysis in a Tertiary Care Center.Cureus. 2024 Mar 13;16(3):e56075. doi: 10.7759/cureus.56075. eCollection 2024 Mar. Cureus. 2024. PMID: 38618414 Free PMC article.
-
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2019 Sep 5;9(9):CD001869. doi: 10.1002/14651858.CD001869.pub9. Cochrane Database Syst Rev. 2019. PMID: 31486071 Free PMC article.
-
Bell's Palsy: Description, Diagnosis, and Current Management.Cureus. 2025 Jan 19;17(1):e77656. doi: 10.7759/cureus.77656. eCollection 2025 Jan. Cureus. 2025. PMID: 39974265 Free PMC article. Review.
Cited by
-
The synergistic role of viral infection and immune response in the pathogenesis of facial palsy.J Neurovirol. 2025 Jun;31(3):208-218. doi: 10.1007/s13365-025-01258-7. Epub 2025 May 15. J Neurovirol. 2025. PMID: 40374879 Free PMC article. Review.
References
-
- Alqahtani SA, Alamri SM, Alqahtani SS, Ali NS, Alshahrani AA, Alshahrani OA, et al. Overview of facial nerve paralysis in Saudi Arabia. Int J Pharm Phytopharm Res. 2020;10:72–5.
-
- Alamrani SA, Rummani SM, Khamdan ZR, Alharbi AM, Mohammed A, Alshahrani MA, et al. Awareness of General Adult Population of Saudi Arabia Toward Bell's palsy. Int J Med Dev Countr. 2020;4:1191–7.
-
- Warner MJ, Hutchison J, Varacallo M. StatPearls [Internet] StatPearls Publishing; 2022. Bell palsy.
LinkOut - more resources
Full Text Sources